| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 15/09/2023 | 15:56 | Edgar (US Regulatory) | Form 15-12G - Securities registration termination [Section 12(g)] | NASDAQ:CFMS | Conformis Inc |
| 05/09/2023 | 14:18 | GlobeNewswire Inc. | restor3d Completes Acquisition of Conformis | NASDAQ:CFMS | Conformis Inc |
| 05/09/2023 | 14:14 | Edgar (US Regulatory) | Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities | NASDAQ:CFMS | Conformis Inc |
| 05/09/2023 | 12:13 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:CFMS | Conformis Inc |
| 05/09/2023 | 12:08 | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:CFMS | Conformis Inc |
| 05/09/2023 | 12:01 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:CFMS | Conformis Inc |
| 24/08/2023 | 23:04 | Edgar (US Regulatory) | Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material | NASDAQ:CFMS | Conformis Inc |
| 23/08/2023 | 14:00 | GlobeNewswire Inc. | Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Conformis Stockholders Vote “FOR” the Pending Merger with restor3d | NASDAQ:CFMS | Conformis Inc |
| 21/08/2023 | 22:10 | GlobeNewswire Inc. | Independent Proxy Advisory Firm ISS Recommends Conformis Stockholders Vote “FOR” the Pending Merger with restor3d | NASDAQ:CFMS | Conformis Inc |
| 02/08/2023 | 23:22 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | NASDAQ:CFMS | Conformis Inc |
| 02/08/2023 | 23:15 | GlobeNewswire Inc. | Conformis Reports Second Quarter 2023 Financial Results | NASDAQ:CFMS | Conformis Inc |
| 24/07/2023 | 14:00 | Edgar (US Regulatory) | Form DEFM14A - Definitive proxy statement relating to merger or acquisition | NASDAQ:CFMS | Conformis Inc |
| 14/07/2023 | 22:28 | Edgar (US Regulatory) | Form PREM14A - Preliminary proxy statements relating to merger or acquisition | NASDAQ:CFMS | Conformis Inc |
| 26/06/2023 | 23:27 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (defa14a) | NASDAQ:CFMS | Conformis Inc |
| 23/06/2023 | 04:05 | GlobeNewswire Inc. | Conformis Announces Definitive Agreement to be Acquired by restor3d for a Purchase Price of $2.27 Per Share in Cash | NASDAQ:CFMS | Conformis Inc |
| 11/05/2023 | 23:14 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:CFMS | Conformis Inc |
| 10/05/2023 | 22:56 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:CFMS | Conformis Inc |
| 08/05/2023 | 14:21 | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:CFMS | Conformis Inc |
| 08/05/2023 | 14:05 | GlobeNewswire Inc. | Conformis Reports First Quarter 2023 Financial Results | NASDAQ:CFMS | Conformis Inc |
| 13/04/2023 | 22:30 | GlobeNewswire Inc. | Conformis, Inc. to Announce Financial Results for Its First Quarter on May 8, 2023 | NASDAQ:CFMS | Conformis Inc |
| 24/03/2023 | 21:02 | Edgar (US Regulatory) | Proxy Statement (definitive) (def 14a) | NASDAQ:CFMS | Conformis Inc |
| 21/03/2023 | 12:00 | GlobeNewswire Inc. | Conformis Launches Patient Awareness Campaign to Highlight the Benefits of Personalized Knee Replacement Procedures | NASDAQ:CFMS | Conformis Inc |
| 01/03/2023 | 22:19 | Edgar (US Regulatory) | Securities Registration: Employee Benefit Plan (s-8) | NASDAQ:CFMS | Conformis Inc |
| 01/03/2023 | 22:05 | GlobeNewswire Inc. | Conformis, Inc. Reports Fourth Quarter and Year End 2022 Financial Results | NASDAQ:CFMS | Conformis Inc |
| 21/02/2023 | 22:15 | GlobeNewswire Inc. | Conformis, Inc. to Participate in Upcoming Investor Conferences | NASDAQ:CFMS | Conformis Inc |
| 15/02/2023 | 22:15 | GlobeNewswire Inc. | Conformis, Inc., Bodycad Laboratories, Inc. and Bodycad USA Corp. Announce Settlement of Patent Litigation | NASDAQ:CFMS | Conformis Inc |
| 10/02/2023 | 13:00 | GlobeNewswire Inc. | Conformis Provides Business Update and Reports Preliminary Results for Fourth Quarter and Full-Year 2022 | NASDAQ:CFMS | Conformis Inc |
| 09/02/2023 | 23:29 | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | NASDAQ:CFMS | Conformis Inc |
| 23/01/2023 | 22:30 | GlobeNewswire Inc. | Conformis, Inc. to Announce Financial Results for Its Fourth Quarter and Full-Year 2022 | NASDAQ:CFMS | Conformis Inc |
| 30/11/2022 | 22:30 | GlobeNewswire Inc. | Conformis, Inc. Regains Compliance with Nasdaq’s Minimum Bid Price Rule | NASDAQ:CFMS | Conformis Inc |